.png
)
Feb 22, 2025 In a major regulatory move, India's Central Drug Regulator (CDSCO) have ordered the immediate withdrawal of manufacturing and export permissions for all Tapentadol-Carisoprodol combinations. This decisive action comes in response to growing concerns over their misuse…
The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, Government of India, has taken another significant step towards digital transformation. As per the circular dated 12th February 2025, CDSCO has introduced an online provision for…
Jan 8, 2025 In a significant regulatory move, the Indian government has imposed a nationwide ban on the manufacture, sale, and distribution of all formulations of nimesulide, a commonly used painkiller for animals. The decision, which was officially notified on…
Jan 6, 2025 In a significant development for Micro, Small, and Medium Enterprises (MSME) in the pharmaceutical sector, the Ministry of Health and Family Welfare (MoHFW) has proposed an extension for compliance with the updated Good Manufacturing Practice (GMP) standards…
January 6, 2023 Government of India vide gazette notification no. GSR 922 (E) dated 28.12.2023 has notified new set of rules and regulations for implementation of Good Manufacturing Practices for manufacturing of pharmaceutical products. The new rules are covered under…